GHRP-2: A Hormone Signal Is One Endpoint
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

GHRP-2 is a growth hormone secretagogue: researchers use it to investigate hormone release and related physiology. A larger hormone response does not automatically predict better health. In a small randomized, double-blind experiment, seven healthy men received GHRP-2 or saline. Investigators measured growth hormone and food intake during a laboratory meal. The GHRP-2 condition increased food intake and growth hormone. These short-term results concern appetite and endocrine responses, rather than recovery or muscle performance. The limited sample and acute design leave longer-term effects unresolved. Clinical benefits and safety cannot be ranked from a hormone peak alone.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Laferrère et al. (2005): Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men
https://pmc.ncbi.nlm.nih.gov/articles/PMC2824650/
Primary randomized double-blind placebo-controlled acute human study

EVIDENCE LIMITATIONS
Seven healthy men and acute exposure do not establish general long-term efficacy or safety.
The catalog inherited PMID 9543138, which studies GHRP-6. It is not used as GHRP-2 evidence here.
Do not infer superiority for strength, recovery or longevity from endocrine stimulation.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
GHRP-2: Why a Hormone Peak Cannot Rank Clinical Benefits